The Group's principal activity is to produce medical device products on endovascular technologies for the minimally invasive treatment of vascular diseases and disorders. It operates through two segments: Cardio Peripheral and Neurovascular. The Cardio Peripheral operating segment includes cardiovascular products which are used to treat coronary artery disease, atrial fibrillation and other disorders in heart and peripheral vascular products which are used to treat vascular disease in legs, kidney (or renal), neck (or carotid), and generally all vascular diseases other than in the brain or the heart. The Neurovascular operating segment includes products that are used to treat vascular disease and disorders in the brain, including aneurysms and arterial-venous malformations.
Alacra Alerts:
Receive alerts on the latest reports on ev3, Inc.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
